Clinical characteristics and outcomes of infection with human T-lymphotropic virus in a non-endemic area: a single institution study

Keyphrases

• Clinical Outcomes 100%
• Clinical Characteristics 100%
• Non-endemic 100%
• Human T-cell Leukemia Virus Type 1 (HTLV-1) 100%
• Single Institution Study 100%
• Virus Infection 20%
• Seropositivity 16%
• Human T-lymphotropic Virus 2 16%
• Overall Survival 12%
• Hepatitis C Virus Infection 12%
• Multivariate Analysis 8%
• Virus Detection 8%
• Hepatitis C 8%
• All-cause Mortality 8%
• United States 4%
• Non-associated 4%
• Comorbidity 4%
• Clinical Features 4%
• Median Overall Survival 4%
• Negative Control 4%
• Clinical Data 4%
• Acute Myeloid Leukemia 4%
• Univariate Analysis 4%
• Single Institution 4%
• Patients with Cancer 4%
• Epidemiology 4%
• Clinical Factors 4%
• Control Population 4%
• Epidemiological Data 4%
• Virus Hepatitis 4%
• Hematologic 4%
• Living with 4%
• Cancer Diagnosis 4%
• Small Patients 4%
• Patient Samples 4%
• Adult T-cell Leukemia 4%
• 1-year Mortality 4%
• Co-infection 4%
• Neurologic 4%
• Rheumatologic 4%
• Clinical Comorbidities 4%
• Patient-controlled 4%
• Transplant Evaluation 4%
• Clinical Survival 4%
• Selection Factors 4%

Biochemistry, Genetics and Molecular Biology

• Overall Survival 100%
• Human T-Lymphotropic Virus 1 100%
• Human T-Lymphotropic Virus 2 100%
• Multivariate Analysis 50%
• All Cause Mortality 50%
• Comorbidity 50%
• T Cell 25%
• Sample Size 25%
• Hepatitis C Virus 25%
• Population Dynamics 25%

Immunology and Microbiology

• Human T-Lymphotropic Virus 100%
• Viral Disease 25%
• Hepatitis C 25%
• Overall Survival 20%
• Human T-Lymphotropic Virus 1 20%
• Seropositivity 20%
• Human T-Lymphotropic Virus 2 20%
• All Cause Mortality 10%
• Comorbidity 10%
• T Cell 5%
• Hepatitis Virus 5%
• Sample Size 5%
• Coinfection 5%
• Population Dynamics 5%